-
-
Dr. Mona Bafadhel
-
-
-
Dr. Ron Dandurand
-
-
-
-
Dr. Esther Metting
-
-
-
-
-
-
-
-
-
Prof. Christian Virchow
-
Prof. Sinthia Bosnic-Anticevich

Prof. G. Walter Canonica
Allergist and Pulmonologist
He has been President of WAO-World Allergy Organization, Interasma-Global Asthma Association, currently VicePresident of REG-Respiratory Effectiveness Group.
He is Steering Committee Member of SANI-Severe Asthma Network Italy.
Prof. David Halpin

He is also Honorary Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute (OPRI) in Singapore. He is a member of the Board of Directors of the Global Initiative on Obstructive Lung Diseases (GOLD) and of the GOLD Science Committee. He was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK.
He studied at Oxford University (first class honours) & St Thomas Hospital Medical School, qualifying in 1986. He was awarded an MRC scholarship to undertake a D.Phil. in the Department of Human Anatomy at Oxford University, between his pre-clinical and clinical training. He trained in respiratory medicine at the Brompton Hospital in London.
He is a Fellow of Royal College Physicians, and a Member of the BTS, ERS & ATS.
He has served on various BTS committees.
In 2018 he was elected as a Fellow of ERS in recognition of lifetime excellence and contributions to research, education and clinical leadership in respiratory medicine.
His research is focussed on clinical aspects of COPD and asthma. He has published extensively and frequently gives presentations on COPD and asthma at lectures and meetings around the world.
He was an Associate Editor of Thorax and is on the editorial board of several journals and is a peer reviewer for many others.
Professor Janwillem W.H. Kocks, General Practitioner
Professor of Inhalation Medicine, OPRI, SingaporeDirector GPRI
IPCRG President

He obtained his medical degree in 2004 at the University of Groningen. In January 2005 he started his PhD research within the Groningen Research Institute on Asthma and COPD (GRIAC) resulting in his thesis “Towards health status guided care in COPD”. He combined his PhD training with the specialist training for general practitioner and graduated as general practitioner in March 2009 and obtained his PhD in June 2011.
He visited the Medical Research Institute of New Zealand (headed by Professor Richard Beasley) between July 2013 and February 2014 as senior research fellow and was visiting professor at the Observational & Pragmatic Research Institute (headed by Professor David Price) end of 2017.
He is president of the International Primary Care Respiratory Group (IPCRG).
His current research focuses on diagnosis and individualised management of both asthma and COPD in primary care including improving inhalation technique by education and smart inhalers.
Dr. Kostas Kostikas

Dr Kostikas is a member of GOLD COPD Assembly. He has more than 230 publications in PubMed (h-index 38), focusing on COPD, severe asthma, and new technologies. He is the Editor in Chief of Pneumon Journal (www.pneumon.org), associate editor of COPD: Journal of Chronic Obstructive Pulmonary Disease, and member of the editorial board of American Journal of Respiratory and Critical Care Medicine, PLoS One, Diagnostics and Frontiers in Medicine.
Prof. Therese Laperre
Prof. Andrew Menzies - Gow

Professor of Practice (Respiratory Medicine)
National Heart and Lung Institute
Imperial College
Dr. Marc Miravitlles

Dr. Pilar Rivera Ortega

Wythenshawe Hospital
Manchester University NHS Foundation Trust
United Kingdom
Dr Rivera Ortega is a Respiratory Consultant with expertise in interstitial lung diseases (ILD), who has been working in the ILD unit of Wythenshawe Hospital since April 2018, for Manchester University NHS Foundation Trust. She is the lead of the Familial Interstitial Pneumonia clinic and the lead of ILD bronchoscopy list at Wythenshawe Hospital. Dr Rivera Ortega has spent three years as a clinical/research fellow and trained as a specialist in ILD with Dr Maria Molina-Molina at Bellvitge University Hospital, Barcelona-Spain. She is the former coordinator of the Emerging Spanish ILD group (GEEPID-SEPAR) and current member of the executive board of the Spanish ILD group (EPID-SEPAR). Dr Rivera Ortega participates as principal investigator and co-investigator of several clinical trials related to ILD. She has previous experience in the development of a rapid circuit for assessment of ILDs.
Prof. Nikos Papadopoulos

He has extensive clinical and educational experience in paediatric allergy, having headed for many years a unit caring for more than 7,000 children with allergic diseases yearly, implementing state-of-the-art interventions and training medical students, resident paediatricians and allergists. His research focus is the interface between infection and allergic disease, with an emphasis on asthma exacerbations and food allergy. He is the Coordinator of the EU-funded CURE project. He has extensive collaborations in the context of EU projects, such as PreDicta, GA2LEN, EUROPREVALL, iFAAM and FAST. Prof. Papadopoulos has published over 300 papers (h-index: 70), has received several international awards and is invited to speak at international scientific meetings some 30 times a year. Moreover, he has served or is serving on the boards of EAACI, GA2LEN, WAO, EFA and ARIA. He was the 2013–2015 President of EAACI and is currently the President of the Respiratory Effectiveness Group (REG).
Prof. Alberto Papi

He trained in Respiratory Medicine at the University of Parma, before spending 4 years in the UK as a Clinical Research Fellow at the University of Southampton, where he is an Honorary Clinical Lecturer.
He has coordinated several pivotal studies in asthma and COPD, and has authored more than 350 articles in peer-reviewed journals.
Dr. James Paton

He has a long-standing interest in asthma audit and started the UK paediatric asthma audit. He was the paediatric member of the writing committee National Review of Asthma Deaths Report “Why Asthma Still Kills”. He was co-chair for the last BTS SIGN asthma guideline in 2019.
Dr. Paulo Pitrez
Pediatric Pulmonology Division, Hospital Moinhos de Vento
Prof. Celeste Porsbjerg
Prof. David Price
Prof. Helen Reddel

As Chair of the Global Initiative for Asthma (GINA) Science Committee, Dr Reddel has led major evidence-based changes in clinical recommendations for asthma management, with a strong focus on improving patient-health professional communication, and on making guidelines not only evidence-based, but also patient-centred and practical.
Dr Reddel has a long history of collaborative research with pharmacists and family physicians to address practical barriers to care of patients with asthma and COPD. Her current research includes investigating clinical trajectories and underlying mechanisms in a real-world cohort of patients with asthma and/or COPD; strategies for identifying and reducing risk in mild asthma; population monitoring of asthma and COPD; and qualitative research about patient perspectives in mild and severe asthma.
Nicolas Roche

Professor Roche is a member of the GOLD science committee, President of Société de Pneumologie de Langue Française, co-chair of the 2018 ERS Congress and member of the American Thoracic Society. He is guidelines director of the ERS and member of the ERS Clinical Research Collaboration (CRC) working group and ERS Science Council, vice-president of the Respiratory Effectiveness Group and member of the Asthma Drug Management Improvement Team. He coordinates French guidelines on COPD and is a consultant for French institutions for the development of national projects on COPD.
Professor Roche has authored more than 250 research articles in international peer-reviewed journals and edited or co-edited several books on COPD. He is Associate Editor of the European Respiratory Review and the Clinical Respiratory Journal.
Dr. Dermot Ryan

Prof. Joan Soriano
Associate Professor of Medicine, Universidad Autónoma de Madrid, Cátedra UAM-Linde, and Senior Investigator at the Instituto de Investigación Hospital Universitario de la Princesa-IISP, Madrid, Spain
Prof. Omar Usmani

His clinical research themes are Inhaled Drug Delivery, Airways Physiology, Lung Imaging, Respiratory Pharmacology and Tele-monitoring / E-health. He is Secretary of Assembly 5 (Asthma and COPD) at the ERS, Chair of UKIG (UK Inhaler Group), Vice-Chair of Drug Delivery to the Lungs, and Europe Liaison of International Society of Aerosols in Research (ISAM).
In 2012, he was awarded a UK National Institute for Health Research (NIHR) Career Development Fellowship, the first time this award category was given to Respiratory Science research in the UK. In 2015, received one of the highest accolades in aerosol science, the Thomas T Mercer Award from the American Association of Aerosol Research (AAAR) and ISAM, recognizing his international research excellence in pharmaceutical aerosols and inhalable materials. He is currently clinical lead on an EU Horizon 2020 consortium project ‘myaircoach’ focusing on the tele-monitoring of patients with asthma and is PI of an FDA awarded project on understanding patient perceptions in breathing from a DPI.
Samantha Walker PhD
Director of Research & Innovation, Asthma + Lung UK
Prof. Alexander Moeller

Prof Moeller trained at University Children’s Hospital Zurich and Princess Margaret Hospital in Perth, WA and obtained his postdoctoral lecture qualification at the University of Zurich (UZH) 2010 and is adjunct Professor at UZH since 2018. He runs a very active specialist clinical service for the whole range of paediatric pulmonology and is leading an active research group at University Children’s Hospital Zurich. His main research focus is the non-invasive assessment of airway inflammation in children by breath analysis and he is involved as PI in clinical trials in the context of the European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN).
Prof Moeller is an associate editor for the Journal Pediatric Pulmonology. He has authored over 80 papers and book chapters on paediatric respiratory diseases.
Prof. Clare Murray

Prof. Job van Boven

He obtained his PharmD and PhD at the University of Groningen (The Netherlands), where his thesis focused on the cost-effectiveness of adherence enhancing interventions in patients with COPD. After his PhD research, he completed fellowships at the University of Colorado (USA), Monash University (Australia) and the Hospital Universitario Son Espases (Spain).
He is (co)author of >100 scientific publications, supervisor of 9 PhD students and received several research prices & grants (totalling>€6 million). Having interest and wide experience in both medication adherence and health economic methods, his mission is to find novel, cost-effective ways to make better use of our respiratory medications in order to maximize both patients’ and societal benefits. Amongst others, his research aims to provide evidence for optimal implementation of drug-device technologies (digital inhalers, electronic pill bottles and smart spacers) in daily clinical practice.
Dr. Iñigo Ojanguren
Dr. Maria Molina-Molina

Dr. Désirée Larenas-Linnemann

- Directora Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Mexico City
- GINA Advocate for Mexico 2020-ongoing
- Chair 8 National Guidelines: a.o. Integrated asthma managemente (MIA 2021), Immunotherapy 2019, Consensus Atopic Derm 2018, Asthma 2017, Urticaria 2014 and ARIA México 2014
>190 pubmed indexed publications
www.dralarenas.com
Prof. Todor A. Popov

Sofia, February 2022
Prof Dr Renaud Louis
Adapted January 2022
Prof. Jean Bousquet

Jean Bousquet was Chairman of the WHO Global Alliance against Chronic Respiratory Diseases (GARD, 2006-2013) and is co-coordinator of the Action Plan B3 of the European Innovative Partnership on Active and Healthy Ageing (EIP on AHA, Action 5: Care Pathways, Integrated Care for Chronic Diseases).
For many years, his research was focused on allergens and immunotherapy including pioneered work in sub-lingual immunotherapy. His focus was then directed towards asthma research and he performed studies involving bronchial biopsies which demonstrated inflammation in asthma. He proposed and demonstrated the concept of airways remodelling in asthma. He also examined the relationships between asthma and rhinitis as a co-morbidity, particularly in severe patients. He has now turned his research interest to systems biology to understand the mechanisms of allergy and chronic diseases and has proposed a new definition for IgE-mediated diseases (MeDALL).
Jean Bousquet has public health interest, in particular as the chairman of the WHO GARD. The main activity of GARD was to help implementing chronic respiratory disease programmes at national (e.g. China, Italy, Kyrgystan, Turkey) or regional (Minais Gerais, Brazil) levels and in the UN Resolution A/RES/64/265. He is currently leading the Région Languedoc-Roussillon-Midi-Pyrénées programme on chronic diseases for an active and healthy ageing (Reference Site of the European Innovative Partnership on Active and Healthy Ageing).
Jean Bousquet has always combined his research, clinical and public health interests. He performed translational research from a clinical observation in his clinic to the assessment of the disease burden (epidemiology), the understanding of the mechanisms and the implementation of the results to populations developing guidelines, national or international programmes with WHO.
Jean Bousquet has edited and authored 10 books including one allergy textbook, and over 900 peer-reviewed papers posted in Pubmed. He has over 1,150 papers listed in Research Gate. He has published 4 of the 20 most cited papers in asthma. His Hirsch (H) factor is 112. He was listed as one of the 400 most cited authors in biomedical science (Scopus 1996-2011).
He was the editor of the European Respiratory Review and of Allergy (second ranking journal in the field, 2003-2009, IF: 6.2). He is currently the editor of Clinical Translational Allergy and is or has been the associate editor of over 10 journals (IF: 3.8).
Among the many awards, Jean Bousquet is Doctor Honoris Causa of the University 1 of Moscow, Modena and Warsaw.
Prof. Ruby Pawankar, MD, Ph.D, FRCP, FAAAAI

Dept. of Pediatrics,
Nippon Medical School, Tokyo, Japan